An overlooked mechanism in lung cancer tumors may help explain why most patients don't respond to immunotherapy, according to new research led by Olga Anczuków, professor at The Jackson Laboratory for Genomic Medicine in Farmington, Connecticut, and deputy director of the NCI-designated Jackson Laboratory Cancer Center.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Scientists uncover 'hidden switch' that helps cancer cells hide from the immune system | 0 | 4.74 | 13-08-2026 |
| 2 | An overlooked immune cell offers a way to treat deadliest lung cancers | 0 | 9.98 | 15-10-2026 |
| 3 | Researchers show how leukemia cells 'hide' from treatment | 0 | 9.92 | 23-10-2026 |
| 4 | Lung transplant dramatically improves survival for patients with terminal lung cancer, study finds | 7 | 8 | 08-07-2026 |
| 5 | Создан подход для оценки эффективности иммунотерапии рака легких | 0 | 0 | 04-08-2025 |
| 6 | A precision T-cell therapy stalls treatment-resistant cancers in clinical trial | 0 | 10.41 | 23-10-2026 |
| 7 | USC scientists just unlocked an endless supply of cancer-fighting immune cells | 0 | 13.57 | 29-06-2026 |
| 8 | Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study | 0 | 8.43 | 24-10-2026 |
| 9 | Reprogramming tumor microenvironment could improve prospects for treatment of pancreatic cancer | 0 | 5.75 | 23-10-2026 |